NASDAQ:LIXT
Lixte Biotechnology Holdings, Inc.
- Stock
Last Close
2.31
26/07 20:00
Market Cap
5.08M
Beta: −0.30
Volume Today
9.06K
Avg: 443.13K
PE Ratio
−0.76
PFCF: −1.01
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 30.46K - | 30.46K 0% | ||||||||||
average payables | 94.09K - | 115.15K 22.38% | 140.81K 22.28% | 159.34K 13.16% | 235.81K 48.00% | 253.62K 7.55% | 169.38K 33.22% | 166.92K 1.45% | 208.13K 24.69% | 227.86K 9.48% | 114.88K 49.58% | |
average receivables | 100K - | 100K 0% | 7.18K - | 7.18K 0% | ||||||||
book value per share | 0.34 - | 0.36 5.37% | 0.40 11.48% | 0.27 32.79% | 1.07 297.41% | 4.21 293.63% | 2.18 48.26% | 4.44 104.03% | 3.56 20.00% | 0.33 90.82% | 2.09 538.64% | |
capex per share | ||||||||||||
capex to depreciation | ||||||||||||
capex to operating cash flow | ||||||||||||
capex to revenue | ||||||||||||
cash per share | 0.69 - | 0.35 49.77% | 0.17 52.43% | 0.25 51.04% | 1.40 460.18% | 4.36 210.67% | 2.33 46.67% | 4.50 93.29% | 3.58 20.36% | 0.34 90.55% | 2.19 548.39% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 365 - | |||||||||||
debt to assets | 0.21 - | 0.06 70.08% | -0.20 420.12% | -0.14 33.52% | -0.04 67.28% | -0.05 9.09% | -0.09 83.06% | -0.06 - | -0.07 19.38% | |||
debt to equity | 0.51 - | 0.13 74.31% | -0.39 402.13% | -0.27 29.93% | -0.06 77.71% | -0.05 16.60% | -0.10 91.18% | -0.06 - | -0.08 20.87% | |||
dividend yield | 0.00 - | 0.00 105.80% | ||||||||||
earnings yield | -0.25 - | -0.26 2.06% | -0.21 20.40% | -0.32 54.04% | -0.20 38.30% | -0.04 80.14% | -0.05 34.68% | -0.09 73.83% | -0.42 360.17% | -0.08 81.36% | -1.13 1,343.13% | |
enterprise value | 4.93M - | 10.61M 115.24% | 13.78M 29.83% | 6.51M 52.77% | 7.90M 21.46% | 50.44M 538.11% | 42.93M 14.89% | 30.68M 28.53% | 11.21M 63.46% | 75.17M 570.57% | 298.73K 99.60% | |
enterprise value over ebitda | -3.59 - | -5.20 45.06% | -5.65 8.52% | -3.05 46.01% | -4.37 43.28% | -23.59 440.14% | -17.24 26.92% | -9.41 45.43% | -1.67 82.27% | -11.93 615.23% | -0.06 99.51% | |
ev to operating cash flow | -4.18 - | -6.49 55.30% | -6.32 2.65% | -3.88 38.59% | -5.60 44.28% | -33.38 496.36% | -25.64 23.18% | -14.39 43.86% | -2.71 81.20% | -16.30 502.40% | -0.07 99.57% | |
ev to sales | 68.89 - | |||||||||||
free cash flow per share | -1.70 - | -2.21 29.78% | -2.80 26.55% | -2.10 24.83% | -1.52 27.79% | -1.54 1.58% | -1.50 2.84% | -1.89 26.16% | -3.07 62.68% | -0.29 90.52% | -2.24 668.74% | |
free cash flow yield | -0.22 - | -0.15 29.70% | -0.16 2.96% | -0.25 58.28% | -0.15 38.69% | -0.03 81.99% | -0.04 33.15% | -0.06 62.13% | -0.26 333.38% | -0.06 77.84% | -0.95 1,565.06% | |
graham net net | 0.23 - | -0.02 109.01% | 0.03 249.80% | -0.02 175.63% | 1.00 4,373.14% | 4.15 313.45% | 2.12 48.80% | 4.30 102.75% | 3.36 22.03% | 0.31 90.66% | 2.03 547.75% | |
graham number | 3.90 - | 5.50 40.90% | 5.74 4.44% | 4.03 29.88% | 6.84 69.93% | 14.36 109.95% | 10.24 28.69% | 17.01 66.13% | 20.00 17.55% | 1.71 91.44% | 11.16 552.31% | |
income quality | 0.86 - | 0.59 31.12% | 0.76 29.34% | 0.79 2.75% | 0.78 0.62% | 0.71 9.29% | 0.69 3.15% | 0.65 4.84% | 0.62 5.68% | 0.73 18.65% | 0.84 15.52% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -458.28K - | -36.41K 92.05% | -33.93K 6.82% | -11.67K 65.62% | -1.32K 88.72% | -434.30 67.00% | -889.07 - | -906.45 1.96% | -711.15 21.55% | 313.57 144.09% | ||
interest debt per share | 0.17 - | 0.05 72.87% | -0.16 435.98% | -0.07 53.02% | -0.06 13.15% | -0.21 228.03% | -0.21 1.27% | 0.00 101.53% | -0.22 6,831.98% | -0.02 88.88% | -0.01 65.26% | |
inventory turnover | ||||||||||||
invested capital | 0.51 - | 0.13 74.31% | -0.39 402.13% | -0.27 29.93% | -0.06 77.71% | -0.05 16.60% | -0.10 91.18% | -0.06 - | -0.08 20.87% | |||
market cap | 5.41M - | 10.66M 97.15% | 13.80M 29.53% | 6.71M 51.41% | 9.21M 37.31% | 54.71M 494.03% | 45.53M 16.79% | 35.75M 21.47% | 16.03M 55.15% | 80.53M 402.22% | 4.50M 94.41% | |
net current asset value | 236.27K - | 265.86K 12.53% | 312.33K 17.48% | 214.76K 31.24% | 995.04K 363.33% | 4.12M 314.41% | 2.43M 40.97% | 5.01M 105.90% | 4.79M 4.42% | 5.17M 7.83% | 3.99M 22.66% | |
net debt to ebitda | 0.35 - | 0.02 93.70% | 0.01 52.42% | 0.09 804.08% | 0.72 670.44% | 2.00 177.00% | 1.04 47.78% | 1.55 48.93% | 0.72 53.82% | 0.85 18.37% | 0.83 2.81% | |
net income per share | -1.98 - | -3.74 88.41% | -3.66 2.16% | -2.68 26.84% | -1.94 27.34% | -2.18 11.98% | -2.14 1.72% | -2.89 35.27% | -5.00 72.74% | -0.40 92.03% | -2.66 566.28% | |
operating cash flow per share | -1.70 - | -2.21 29.78% | -2.80 26.55% | -2.10 24.83% | -1.52 27.79% | -1.54 1.58% | -1.50 2.84% | -1.89 26.16% | -3.07 62.68% | -0.29 90.52% | -2.24 668.74% | |
payables turnover | ||||||||||||
receivables turnover | 1 - | |||||||||||
research and ddevelopement to revenue | 10.46 - | |||||||||||
return on tangible assets | -2.46 - | -5.13 108.19% | -4.77 7.01% | -4.93 3.27% | -1.32 73.16% | -0.49 62.79% | -0.89 81.89% | -0.62 30.24% | -1.32 111.87% | -1.13 14.25% | -1.18 4.12% | |
revenue per share | 0.26 - | |||||||||||
roe | -5.82 - | -10.40 78.80% | -9.13 12.23% | -9.94 8.85% | -1.82 81.72% | -0.52 71.55% | -0.98 89.96% | -0.65 33.70% | -1.41 115.94% | -1.22 13.19% | -1.27 4.33% | |
roic | -3.87 - | -8.00 106.97% | -13.95 74.32% | -13.71 1.68% | -1.94 85.87% | -0.54 71.94% | -1.11 104.32% | -0.65 41.35% | -1.50 130.13% | -1.32 11.86% | -1.27 3.57% | |
sales general and administrative to revenue | 3.77 - | |||||||||||
shareholders equity per share | 0.34 - | 0.36 5.37% | 0.40 11.48% | 0.27 32.79% | 1.07 297.41% | 4.21 293.63% | 2.18 48.26% | 4.44 104.03% | 3.56 20.00% | 0.33 90.82% | 2.09 538.64% | |
stock based compensation to revenue | 2.75 - | |||||||||||
tangible asset value | 236.27K - | 265.86K 12.53% | 312.33K 17.48% | 214.76K 31.24% | 995.04K 363.33% | 4.13M 314.64% | 2.43M 41.00% | 5.01M 105.90% | 4.79M 4.42% | 5.17M 7.83% | 3.99M 22.66% | |
tangible book value per share | 0.34 - | 0.36 5.37% | 0.40 11.48% | 0.27 32.79% | 1.07 297.41% | 4.21 293.63% | 2.18 48.26% | 4.44 104.03% | 3.56 20.00% | 0.33 90.82% | 2.09 538.64% | |
working capital | 236.27K - | 265.86K 12.53% | 312.33K 17.48% | 214.76K 31.24% | 995.04K 363.33% | 4.12M 314.41% | 2.43M 40.97% | 5.01M 105.90% | 4.79M 4.42% | 5.17M 7.83% | 3.99M 22.66% |
All numbers in USD (except ratios and percentages)